Influence of the combined use of septomyrin and chlorhexidineon bacterial load of purulent wounds
https://doi.org/10.51523/2708-6011.2021-18-1-5
Abstract
Objective: to study the MIC90 of the most commonly used antiseptics for the main representatives of the microflora of purulent wounds and to study the influence of the most effective in vitro antiseptics on the bacterialload of the wound surface in patients with purulent wounds.
Material and methods. Bacteriological studies determining the MIC90values of antiseptic drugs were performed on 70 clinical isolates. Clinical studies determining the level of the bacterial load of the wound surface were performed in 30 patients with purulent wounds.
Results. Septomyrin and 0.02 % chlorhexidine bigluconate have been found to be the most active drugs against the main representatives of the microflora of purulent wounds in our region. In the combined use of septomyrin and chlorhexidine, the bacterial load of the wounds decreased below the critical level already 2 days after surgical debridement (p < 0.01), while in the single application of septomyrin, this had occurred only by the fifth day (p < 0.01), and chlorhexidine — by the sixth day (p<0.01).
Conclusion. The combined use of septomyrin and 0.02 % chlorhexidine bigluconate is characterized by high clinical effectiveness in the local treatment of purulent wounds during the first phase of the wound healing process.
About the Author
S. D. Fedzianin
Vitebsk State Order of Peoples’ Friendship Medical University
Belarus
Belarus
Федянин Сергей Дмитриевич, к.м.н., доцент, доцент кафедры госпитальной хирургии, Vitebsk
References
1. Kosinec AN, Kosinec VA, Struchkov JuV. Infekcija v hirurgii. Minsk, RB; 2012. 496 p. (in Russ.)
2. Fedjanin SD, Okulich VK, Konopel'ko EA, Kovalenko AA, Krishtopov LE, Sachek MG, Sokolovskij VO. Sravnitel'nyj analiz jetiologicheskoj struktury i chuvstvitel'nosti k antibiotikam osnovnyh vozbuditelej hirurgicheskih infekcij v stacionarah goroda Vitebska. Vestnik VGMU. 2012;11(3):73-79. (in Russ.)
3. ShtanjukEA, MinuhinVV, LjapunovNA, LysokobylkaAA. Izuchenie antimikrobnoj aktivnosti mazej, soderzhashhih dioksidin, na standartnyh shtammah osnovnyh vozbuditelej ranevoj infekcii [Jelektronnyj resurs]. Universum: Medicina i farmakologija. 2014;5(6). [data obrashhenija: 2020Apr21]. http://7universum.com/ru/med/archive/item/1292 (in Russ.)
4. Popov DA, Anuchina NM,Terent'evAA,Kostjuk GV,Blatun LA,Rusanova EV,Aleksandrova IA,Phakadze TJa,Bogomolova NS, Terehova LP. Dioksidin: antimikrobnaja aktivnost' i perspektivy klinicheskogo primenenija na sovremennom jetape. Antibiotiki i himiote rapija.2013;58(3-4):37-42. (in Russ.)
5. Blednov AV. Rezul'taty primenenija perevjazochnyh sredstv «Kombiksin» i «Diosept» v klinike (klinicheskie ispytanija perevjazochnyh sredstv). Recept. 2009;63(1):118-124. (in Russ.)
6. Kuzin MI, Kostjuchenok BM. Rany i ranevaja infekcija. Moskva; 1990. 591 p. (in Russ.)
7. Dolgin AS, Karchmit EV, Hlusenkov AA. Opyt primenenija antisepticheskih lekarstvennyh sredstv i sovremennoj innovacionnoj razrabotki kompanii «Belaseptika» - «Mukosanin» dlja profilktikinozokomial'nyh infekcij v uslovijah UZ «Vitebskij oblastnoj klinicheskij onkologicheskij dispanser» [Jelektronnyj resurs]. Belaseptika. 2015. [data obrashhenija: 2020 Apr 21]. https://belaseptika.by/know/experience-in-theapplication- of-antiseptic-/ (in Russ.)
8. Primenenie antisepticheskih lekarstvennyh sredstv v zdravoohranenii na fone rezistentnosti mikroorganizmov k antibiotikam i sovremennaja innovacionnaja razrabotka kompanii «BelAseptika» - «Mukosanin»[Jelektronnyj resurs]. Belaseptika. 2018. [data obrashhenija: 2020 Apr 21]. https://belaseptika.by/know/the-use-of-antisepticdrugs-in-health-care-against-the-background-ofresistance-of-microorganisms-to/ (in Russ.)
9. Kosinec AN,Okulich VK, BulavkinVP. Antibakterial'naja terapija v gnojnoj hirurgii. Vitebsk, RB; 2002. 600 p. (in Russ.)
10. JakovlevVP, Jakovlev SV.Racional'naja antimikrobnaja farmakoterapija. Moskva, RF; 2003.1008 p. (in Russ.)
11. Popov DA, Anuchina NM. Sravnitel'naja aktivnost'in vitro antisepticheskih preparatov hlorgeksidina bigljukonata i miramistina v otnoshenii predstavitelej nozokomial'noj mikroflory. Bjulleten' NCSSH im. AN Bakuleva RAMN. 2013;14(S6):214. (in Russ.)
12. Dunaevskij AM, Kirichenko IM. Klinicheskoe obosnovanie ispol'zovanija preparata Miramistin v terapii infekcionno-vospalitel'nyh zabolevanij respiratornoj sistemy. Poliklinika. 2014;1:66-68. (in Russ.)
13. Bagaeva VV, Popova VM, Pashkova GS, Isadzhanjan KE, Nikitin VV, Zhilenkov EL.Izuchenie jeffektivnosti i bezopasnosti primenenija antimikrobnyh sredstv. Issledovanija i praktika v medicine. 2015;2(3):35-42. (in Russ.)
Review
For citations:
Fedzianin S.D. Influence of the combined use of septomyrin and chlorhexidineon bacterial load of purulent wounds. Health and Ecology Issues. 2021;18(1):35-40. (In Russ.) https://doi.org/10.51523/2708-6011.2021-18-1-5
Views: 447
Email this article 